Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adagene, AIDS Clinical Trials Group, Astrazeneca, Beigene, Bioheng, Biontech, Brii, Cstone, Medison, Moderna, Pfizer, Shionogi, Sinomab, Swedish Orphan Biovitrum.